Shire studies SHP640

Shire studies SHP640 for infectious conjunctivitis The first U.S. patient has been enrolled in a phase 3 clinical trial for Shire’s SHP640, a combination broad-spectrum antiseptic and corticosteroid being evaluated for treating infectious keratitis in adults and...
On